Tscan therapeutics to participate in upcoming investor conferences

Waltham, mass., nov. 11, 2021 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a biopharmaceutical company focused on the development of t-cell receptor (tcr) engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will participate virtually at the following upcoming investor conferences:

TCRX Ratings Summary

TCRX Quant Ranking